POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 5.819
EU - Europa 3.540
AS - Asia 3.331
SA - Sud America 548
AF - Africa 269
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.529
Nazione #
US - Stati Uniti d'America 5.705
SG - Singapore 1.182
IT - Italia 868
VN - Vietnam 717
CN - Cina 559
RU - Federazione Russa 533
BR - Brasile 436
UA - Ucraina 382
HK - Hong Kong 332
DE - Germania 297
FR - Francia 254
IE - Irlanda 245
FI - Finlandia 226
SE - Svezia 219
CI - Costa d'Avorio 159
DK - Danimarca 140
TR - Turchia 133
GB - Regno Unito 121
IN - India 99
KR - Corea 84
NL - Olanda 76
AT - Austria 51
CA - Canada 49
ZA - Sudafrica 47
AR - Argentina 40
BD - Bangladesh 40
MX - Messico 38
MA - Marocco 28
PL - Polonia 28
ES - Italia 26
IQ - Iraq 22
ID - Indonesia 21
JP - Giappone 21
EC - Ecuador 20
AU - Australia 16
RO - Romania 16
PH - Filippine 15
VE - Venezuela 15
BE - Belgio 13
PK - Pakistan 13
UZ - Uzbekistan 13
LT - Lituania 12
CO - Colombia 11
CL - Cile 10
TH - Thailandia 10
SA - Arabia Saudita 9
JM - Giamaica 6
JO - Giordania 6
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
EG - Egitto 5
HR - Croazia 5
IL - Israele 5
PY - Paraguay 5
TN - Tunisia 5
EU - Europa 4
LB - Libano 4
MY - Malesia 4
PA - Panama 4
PE - Perù 4
RS - Serbia 4
TW - Taiwan 4
UY - Uruguay 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
MD - Moldavia 3
NP - Nepal 3
OM - Oman 3
SY - Repubblica araba siriana 3
AO - Angola 2
BB - Barbados 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
PT - Portogallo 2
SM - San Marino 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
Totale 13.512
Città #
Ashburn 851
Singapore 741
Dallas 699
Chandler 422
Jacksonville 382
Hong Kong 320
San Jose 282
Dublin 240
Boardman 235
Ho Chi Minh City 222
Fairfield 203
New York 174
Hanoi 166
Abidjan 159
Wilmington 151
Los Angeles 126
Beijing 123
The Dalles 121
Helsinki 117
Marche 113
Council Bluffs 100
Des Moines 99
Lauterbourg 99
Houston 86
Moscow 85
Lawrence 84
Princeton 83
Seattle 83
San Mateo 80
Munich 74
Ancona 71
Ann Arbor 69
Orem 63
Woodbridge 62
Hefei 60
Cambridge 59
Milan 55
Turin 53
Da Nang 44
Buffalo 40
Turku 39
Chennai 38
Centro 37
Chicago 36
Haiphong 36
San Diego 36
São Paulo 36
Vienna 34
Amsterdam 29
Johannesburg 29
Shanghai 27
Tolentino 27
London 26
Recanati 26
Rome 23
Stockholm 23
Brooklyn 22
Montreal 21
Nuremberg 21
Wuhan 20
Denver 19
Washington 19
Tokyo 18
Warsaw 17
Redmond 16
Ankara 15
Berlin 15
Boston 15
Manchester 15
Mexico City 15
Atlanta 14
Aversa 14
Guangzhou 14
Poplar 14
Santa Clara 14
Belo Horizonte 13
Brussels 13
Curitiba 13
Brasov 12
Frankfurt am Main 12
Biên Hòa 11
Hải Dương 11
Pavia 11
Quito 11
Rio de Janeiro 11
Tashkent 11
Civitanova Marche 10
Mumbai 10
Phoenix 10
Pune 10
Salt Lake City 10
San Francisco 10
Wuxi 10
Baghdad 9
Delhi 9
Istanbul 9
Naples 9
New Delhi 9
Paris 9
Toronto 9
Totale 8.378
Nome #
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 213
Paraoxonase-2 in osteosarcoma: potential for the development of a targeted anticancer therapy 188
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 185
Clinical performance and utility of a NNMT-based urine test for bladder cancer 178
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 174
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 173
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 171
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 169
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 165
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 161
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 158
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 158
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 157
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 155
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 155
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 154
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 153
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 153
Involvement of the oral cavity in psoriasis: results of a clinical study 152
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 151
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 151
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 149
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 147
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 147
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 147
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 147
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 145
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 144
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 139
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 139
Inflammatory cytokines pattern in recurrent miscarriage. 137
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 136
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 136
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 134
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 133
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 133
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 131
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 129
Enhancing cisplatin efficacy in triple-negative breast cancer through pon2 silencing: insights from FTIRM analysis 128
Treatment of osteosarcoma and Merkel cell carcinoma cell lines with inhibitors of nicotinamide N-methyltransferase: potential for the development of targeted therapeutic strategy 128
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 128
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 126
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 126
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 124
Paraoxonase-2 expression in oral squamous cell carcinoma 124
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 123
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 120
CSCs selection, characterization and tumorigenic potential in OSCC. 120
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 120
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 119
Inflammatory cytokines pattern in recurrent miscarriage. 119
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 118
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 118
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 117
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 116
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 116
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 116
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 114
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 114
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 114
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 114
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 113
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 113
FTIR Imaging as a new tool for investigating oral tongue squamous cell carcinoma 112
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 112
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 112
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 111
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 111
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 110
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 110
Catecholamine O-Methyltransferase as a Promising Diagnostic and Therapeutic Target in Oral Squamous Cell Carcinoma 108
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 108
Catechol-o-methyltransferase, a promising diagnostic marker for non-invasive detection of human urothelial carcinoma 107
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 104
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 103
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 101
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 101
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 101
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 100
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 99
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 99
Enhanced expression of paraoxonase 2 in human bladder cancer 99
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 98
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 97
Paraoxonase 2 (PON2) expression in bladder cancer 94
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 93
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 92
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 91
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 91
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 90
Espressione di Pokemon nel carcinoma orale. 90
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 89
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 89
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 88
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 88
Tissue and salivary Nicotinamide N-Methyltransferase: promising results for early and non-invasive diagnosis of oral squamous cell carcinoma. 86
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 85
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 85
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 85
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 84
Totale 12.458
Categoria #
all - tutte 59.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 84 110 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20252.146 287 144 101 46 108 30 185 74 400 153 251 367
2025/20266.125 540 382 734 658 711 433 1.129 555 531 452 0 0
Totale 13.863